Developer docs
API playgroundTry for free, no card

Search company profiles

ZooPharm

Full company profile

uuid002ahfv

Namestring
ZooPharm
Legal namestring
ZooPharm
Websiteurl
wildpharm.com
Company typeenum
Private
Founded yearstring
-
Descriptiontext

ZooPharm is a veterinary compounding pharmacy headquartered in Laramie, Wyoming, that formulates and dispenses specialized anesthesia and pain-management medications for non-domestic species, resident wildlife, captive exotic breeds, and companion animals. The company was a wholly owned subsidiary of Wildlife Pharmaceuticals, Inc. (Windsor, Colorado), founded by Dr. Bill Lance, and was acquired by Wedgewood Pharmacy in May 2020, with the ZooPharm brand maintained post-closing. The product portfolio is anchored by two patented formulations: the BAM™ Kit — a combination of Butorphanol tartrate, Azaperone tartrate, and Medetomidine hydrochloride plus a reversal agent used to immobilize a broad range of wildlife and zoo species — and a slow-release buprenorphine prescribed primarily for companion-animal post-operative recovery. ZooPharm also supplies sustained-release analgesics and anesthetics for wildlife and zoo pain management.

The business operates a prescription-based revenue model, distributing compounded preparations directly to veterinary practices serving the wildlife and zoo market segment. ZooPharm holds pharmacy licensure in all 50 U.S. states, giving it near-universal domestic distribution reach for a specialist catalog. Its differentiation rests on a combination of patented drug formulations, 50-state regulatory footprint, and exclusive domain focus on species for which commercially manufactured medications are typically unavailable. The customer base is a long tail of wildlife veterinarians, accredited zoos, and exotic-animal practices; no enterprise anchor customers are disclosed.

Following the 2020 acquisition by Wedgewood Pharmacy — the largest U.S. animal-health compounding pharmacy, majority-owned by New Harbor Capital since 2016 — ZooPharm gained access to Wedgewood's formulary and 50,000+ veterinary prescribers, while contributing its specialty preparations to Wedgewood's broader customer base. The combined entity also created Wedgewood Connect, a 503B outsourcing facility for sterile injectables and ophthalmics, signaling adjacent expansion of the platform relevant to ZooPharm's specialist needs. ZooPharm's website (wildpharm.com) and full integration into Wedgewood's operations make its post-acquisition financials not separately disclosed.

Short descriptiontext

ZooPharm is a Wyoming-based veterinary compounding pharmacy that formulates patented anesthesia and pain-management medications — including the BAM™ Kit and slow-release buprenorphine — for wildlife, zoo, exotic species, and companion animals, operating under 50-state pharmacy licensure and owned by Wedgewood Pharmacy since 2020.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersFort Collins, United States
HQ citystring
Fort Collins
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
veterinary compounding pharmacy, wildlife anesthesia medications, zoo animal pharmaceuticals, exotic animal pain management, immobilization drug combinations
Industry1 code
SECONDARYHLAMAEAL
Veterinary Vaccines (Biologics)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
NAICS code1 code
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code1 code
  • Biological Products, (No Disgnostic Substances)2836
Product category
Veterinary Compounding Pharmacy
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Veterinary Compounding Medications
TypeOthers
Description

Compounded medications customized to the unique needs of animal patients, particularly non-domestic species, wildlife, and zoo animals. Medications are prepared by specially trained pharmacists under strict standards.

wedgewood.com
Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Personnel, Operations, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

ZooPharm is a veterinary compounding pharmacy that prepares specialized anesthesia and pain-management medications for non-domestic species, resident wildlife, captive exotic breeds, and companion animals. Its portfolio includes the patented BAM™ Kit for immobilizing a broad range of species, a patented slow-release buprenorphine for post-operative recovery, and sustained-release analgesics and anesthetics.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

ZooPharm is a veterinary compounding pharmacy that provides specialized veterinary-anesthesia and pain-management medications. The company operates as part of Wildlife Pharmaceuticals, Inc. and serves veterinarians and patients in the wildlife and zoo markets. Its product portfolio includes the patented BAM™ Kit (for immobilization of non-domestic species), patented slow-release buprenorphine (for companion animal post-operative recovery), and sustained-release analgesics and anesthetics for pain management. The company is licensed in all 50 states. Following acquisition by Wedgewood Pharmacy, the ZooPharm brand will be maintained while Wedgewood's animal health formulary becomes available to ZooPharm's client base.

Product and service3 records
1BAM™ Kit
CategoryVeterinary anesthesia / immobilization
Description

A patented drug combination (Butorphanol tartrate, Azaperone tartrate, and Medetomidine hydrochloride) plus a reversal agent used to immobilize a broad range of wildlife, zoo, and non-domestic species during veterinary procedures.

2Slow Release Buprenorphine
CategoryVeterinary pain management
Description

A patented, slow-release buprenorphine formulation prescribed primarily to companion animals for post-operative recovery and pain management.

3Sustained-Release Analgesics and Anesthetics
CategoryVeterinary pain management
Description

Sustained-release pain management medications used to manage pain in wildlife, zoo species, captive exotic breeds, and companion animals.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Wedgewood Pharmacy
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-05-14
Description

Wedgewood Pharmacy has agreed to acquire Wildlife Pharmaceuticals, Inc., Windsor, Colorado, and its wholly owned pharmacy subsidiary, ZooPharm, Laramie, Wyoming. The transaction was expected to close within 90 days, pending regulatory approvals. Wedgewood Pharmacy intends to maintain the ZooPharm brand while making Wedgewood Pharmacy's extensive animal health formulary available to ZooPharm's client base. ZooPharm's specialized preparations also will be offered to Wedgewood Pharmacy's veterinary customers.

wedgewood.com
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeOthers
Description

Global supplier of pharmaceutical compounding ingredients, equipment, and bases to compounding pharmacies including 503A and 503B facilities. Adjacent ecosystem participant enabling compounding pharmacies like ZooPharm to source APIs and excipients.

2Stokes Pharmacy
TypeDirect peer
Description

Veterinary compounding pharmacy serving companion animal, equine, and exotics markets with customized formulations. Comparable business model (state-regulated compounding for animal health) and overlapping prescriber base with ZooPharm.

TypeDirect peer
Description

Animal-health compounding pharmacy acquired by Wedgewood in July 2018, headquartered in Scottsdale, Arizona. Direct comparable: a veterinary compounding pharmacy serving companion animal and equine prescribers, now operating alongside ZooPharm within the Wedgewood portfolio.

4Wedgewood Pharmacy
TypeDirect peer
Description

Acquirer of ZooPharm in 2020 and the largest animal health compounding pharmacy in the U.S. Operates state-licensed compounding facilities serving 50,000+ prescribers with a broad veterinary and human health formulary; directly comparable business model (compounding pharmacy for animal health) and now distributes ZooPharm's specialty formulations.

TypeBroad incumbent
Description

Major animal health pharmaceutical company offering a full portfolio of therapeutics, including pain management and companion animal products. Broad incumbent with overlap in the pain/anesthesia therapeutic category ZooPharm addresses.

TypeBroad incumbent
Description

Largest global animal health pharmaceutical company offering vaccines, parasiticides, and pharmaceuticals across companion and livestock species. Broader incumbent whose commercial portfolio competes adjacent to ZooPharm's pain-management and anesthesia franchise.

TypeDirect peer
Description

Former parent company of ZooPharm (Windsor, Colorado). Direct peer as the originating entity behind the BAM Kit and slow-release buprenorphine formulations, with overlapping portfolio in wildlife pharmaceuticals.

TypeDirect peer
Description

Compounding pharmacy serving both human and veterinary markets including exotic and zoo species. Direct comparable on compounding model and exotic-animal customer overlap.

TypeDirect peer
Description

Veterinary compounding supply company providing APIs, bases, and equipment to compounding pharmacists serving veterinary practices. Comparable in the veterinary compounding ecosystem; while not a dispenser, it serves the same customer base of vet compounders.

10Wedgewood Connect (formerly Leiters Enterprises 503B facility)
TypeDirect peer
Description

Wedgewood's 503B outsourcing facility in San Jose, California, acquired in 2020 alongside ZooPharm. Direct comparable as a sibling compounding operation within the same Wedgewood umbrella, but operating under FDA cGMP standards rather than state-only regulation.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ZooPharm

Veterinary Compounding Pharmacywildpharm.com

ZooPharm is a Wyoming-based veterinary compounding pharmacy that formulates patented anesthesia and pain-management medications — including the BAM™ Kit and slow-release buprenorphine — for wildlife, zoo, exotic species, and companion animals, operating under 50-state pharmacy licensure and owned by Wedgewood Pharmacy since 2020.

What ZooPharm does

ZooPharm is a veterinary compounding pharmacy headquartered in Laramie, Wyoming, that formulates and dispenses specialized anesthesia and pain-management medications for non-domestic species, resident wildlife, captive exotic breeds, and companion animals. The company was a wholly owned subsidiary of Wildlife Pharmaceuticals, Inc. (Windsor, Colorado), founded by Dr. Bill Lance, and was acquired by Wedgewood Pharmacy in May 2020, with the ZooPharm brand maintained post-closing. The product portfolio is anchored by two patented formulations: the BAM™ Kit — a combination of Butorphanol tartrate, Azaperone tartrate, and Medetomidine hydrochloride plus a reversal agent used to immobilize a broad range of wildlife and zoo species — and a slow-release buprenorphine prescribed primarily for companion-animal post-operative recovery. ZooPharm also supplies sustained-release analgesics and anesthetics for wildlife and zoo pain management.

The business operates a prescription-based revenue model, distributing compounded preparations directly to veterinary practices serving the wildlife and zoo market segment. ZooPharm holds pharmacy licensure in all 50 U.S. states, giving it near-universal domestic distribution reach for a specialist catalog. Its differentiation rests on a combination of patented drug formulations, 50-state regulatory footprint, and exclusive domain focus on species for which commercially manufactured medications are typically unavailable. The customer base is a long tail of wildlife veterinarians, accredited zoos, and exotic-animal practices; no enterprise anchor customers are disclosed.

Following the 2020 acquisition by Wedgewood Pharmacy — the largest U.S. animal-health compounding pharmacy, majority-owned by New Harbor Capital since 2016 — ZooPharm gained access to Wedgewood's formulary and 50,000+ veterinary prescribers, while contributing its specialty preparations to Wedgewood's broader customer base. The combined entity also created Wedgewood Connect, a 503B outsourcing facility for sterile injectables and ophthalmics, signaling adjacent expansion of the platform relevant to ZooPharm's specialist needs. ZooPharm's website (wildpharm.com) and full integration into Wedgewood's operations make its post-acquisition financials not separately disclosed.

ZooPharm firmographics

Firmographics
Name
ZooPharm
Legal name
ZooPharm
Website
https://wildpharm.com
Company type
Private
Operating status
Acquired
Headcount range
11–50 employees
Short description
ZooPharm is a Wyoming-based veterinary compounding pharmacy that formulates patented anesthesia and pain-management medications — including the BAM™ Kit and slow-release buprenorphine — for wildlife, zoo, exotic species, and companion animals, operating under 50-state pharmacy licensure and owned by Wedgewood Pharmacy since 2020.
Ownership category
akta.pro rank

Where ZooPharm is headquartered

Location

Headquarters

HQ city
Fort Collins
HQ country
United States
HQ region
North America

Offices1 record

Markets served

ZooPharm business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Operations, Technology or R&D, Infrastructure

Revenue model

  1. Veterinary Compounding Medications: Compounded medications customized to the unique needs of animal patients, particularly non-domestic species, wildlife, and zoo animals. Medications are prepared by specially trained pharmacists under strict standards.

Go-to-market motion1 record

Distribution channels1 record

ZooPharm product offering

Product offering

Core offering

ZooPharm is a veterinary compounding pharmacy that prepares specialized anesthesia and pain-management medications for non-domestic species, resident wildlife, captive exotic breeds, and companion animals. Its portfolio includes the patented BAM™ Kit for immobilizing a broad range of species, a patented slow-release buprenorphine for post-operative recovery, and sustained-release analgesics and anesthetics.

Product overview

ZooPharm is a veterinary compounding pharmacy that provides specialized veterinary-anesthesia and pain-management medications. The company operates as part of Wildlife Pharmaceuticals, Inc. and serves veterinarians and patients in the wildlife and zoo markets. Its product portfolio includes the patented BAM™ Kit (for immobilization of non-domestic species), patented slow-release buprenorphine (for companion animal post-operative recovery), and sustained-release analgesics and anesthetics for pain management. The company is licensed in all 50 states. Following acquisition by Wedgewood Pharmacy, the ZooPharm brand will be maintained while Wedgewood's animal health formulary becomes available to ZooPharm's client base.

Differentiator

Problem solved

Functional benefit

Products and services

  • BAM™ Kit A patented drug combination (Butorphanol tartrate, Azaperone tartrate, and Medetomidine hydrochloride) plus a reversal agent used to immobilize a broad range of wildlife, zoo, and non-domestic species during veterinary procedures.
  • Slow Release Buprenorphine A patented, slow-release buprenorphine formulation prescribed primarily to companion animals for post-operative recovery and pain management.
  • Sustained-Release Analgesics and Anesthetics Sustained-release pain management medications used to manage pain in wildlife, zoo species, captive exotic breeds, and companion animals.

Companies that use ZooPharm

Customer profile

Segments1 record

Ideal customer profiles2 records

ZooPharm technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

ZooPharm partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Wedgewood PharmacycoreStrategic or Co-development Partner · 14 May 2020Wedgewood Pharmacy has agreed to acquire Wildlife Pharmaceuticals, Inc., Windsor, Colorado, and its wholly owned pharmacy subsidiary, ZooPharm, Laramie, Wyoming. The transaction was expected to close within 90 days, pending regulatory approvals. Wedgewood Pharmacy intends to maintain the ZooPharm brand while making Wedgewood Pharmacy's extensive animal health formulary available to ZooPharm's client base. ZooPharm's specialized preparations also will be offered to Wedgewood Pharmacy's veterinary customers.

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

ZooPharm competitors and assessment

Company assessment

Others

  • Medisca: Global supplier of pharmaceutical compounding ingredients, equipment, and bases to compounding pharmacies including 503A and 503B facilities. Adjacent ecosystem participant enabling compounding pharmacies like ZooPharm to source APIs and excipients.

Direct peers

  • Stokes Pharmacy: Veterinary compounding pharmacy serving companion animal, equine, and exotics markets with customized formulations. Comparable business model (state-regulated compounding for animal health) and overlapping prescriber base with ZooPharm.
  • Diamondback Drugs: Animal-health compounding pharmacy acquired by Wedgewood in July 2018, headquartered in Scottsdale, Arizona. Direct comparable: a veterinary compounding pharmacy serving companion animal and equine prescribers, now operating alongside ZooPharm within the Wedgewood portfolio.
  • Wedgewood Pharmacy: Acquirer of ZooPharm in 2020 and the largest animal health compounding pharmacy in the U.S. Operates state-licensed compounding facilities serving 50,000+ prescribers with a broad veterinary and human health formulary; directly comparable business model (compounding pharmacy for animal health) and now distributes ZooPharm's specialty formulations.
  • Wildlife Pharmaceuticals, Inc. Former parent company of ZooPharm (Windsor, Colorado). Direct peer as the originating entity behind the BAM Kit and slow-release buprenorphine formulations, with overlapping portfolio in wildlife pharmaceuticals.
  • Apothecary by Elixin (formerly Avrio Pharmacy): Compounding pharmacy serving both human and veterinary markets including exotic and zoo species. Direct comparable on compounding model and exotic-animal customer overlap.
  • Letco Medical (Letco Companies): Veterinary compounding supply company providing APIs, bases, and equipment to compounding pharmacists serving veterinary practices. Comparable in the veterinary compounding ecosystem; while not a dispenser, it serves the same customer base of vet compounders.
  • Wedgewood Connect (formerly Leiters Enterprises 503B facility): Wedgewood's 503B outsourcing facility in San Jose, California, acquired in 2020 alongside ZooPharm. Direct comparable as a sibling compounding operation within the same Wedgewood umbrella, but operating under FDA cGMP standards rather than state-only regulation.

Broad incumbents

  • Elanco Animal Health: Major animal health pharmaceutical company offering a full portfolio of therapeutics, including pain management and companion animal products. Broad incumbent with overlap in the pain/anesthesia therapeutic category ZooPharm addresses.
  • Zoetis: Largest global animal health pharmaceutical company offering vaccines, parasiticides, and pharmaceuticals across companion and livestock species. Broader incumbent whose commercial portfolio competes adjacent to ZooPharm's pain-management and anesthesia franchise.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

ZooPharm social profiles

Digital presence

ZooPharm compliance and trust

Trust signal

Compliance1 record

ZooPharm financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ZooPharm leadership team

Management profile

Number of profiles

ZooPharm funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ZooPharm M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ZooPharm

What does ZooPharm do?

ZooPharm is a veterinary compounding pharmacy that prepares specialized anesthesia and pain-management medications for non-domestic species, resident wildlife, captive exotic breeds, and companion animals. Its portfolio includes the patented BAM™ Kit for immobilizing a broad range of species, a patented slow-release buprenorphine for post-operative recovery, and sustained-release analgesics and anesthetics.

Is ZooPharm a public or private company?

ZooPharm is a private company. It is classified as corporate owned and is currently acquired.

When was ZooPharm founded?

ZooPharm was founded in -1. It employs 11 to 50 people.

Where is ZooPharm based?

ZooPharm is headquartered in Fort Collins, United States, in the North America region.

How does ZooPharm make money?

One revenue line is on record: veterinary Compounding Medications.

Who are ZooPharm's main competitors?

Medisca is listed as an others. Direct peers are Stokes Pharmacy, Diamondback Drugs, Wedgewood Pharmacy, Wildlife Pharmaceuticals, Inc., Apothecary by Elixin (formerly Avrio Pharmacy), Letco Medical (Letco Companies) and Wedgewood Connect (formerly Leiters Enterprises 503B facility). Broad incumbents are Elanco Animal Health and Zoetis.

Does ZooPharm have an API?

No public API is recorded for ZooPharm.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales